What imaging study should be obtained for a patient with short‑term memory loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Imaging for Short-Term Memory Loss

MRI of the brain without contrast is the preferred initial imaging study for evaluating short-term memory loss, with CT head without contrast as an acceptable alternative when MRI is unavailable or contraindicated. 1, 2

Primary Imaging Recommendation

MRI brain without IV contrast should be obtained first because it has superior sensitivity for detecting:

  • Vascular lesions and microhemorrhages 1, 2
  • Hippocampal atrophy patterns 1, 2
  • Rare conditions causing memory impairment 1, 3
  • Treatable structural abnormalities including tumors, subdural hematomas, and normal pressure hydrocephalus 2, 3

Specific MRI Sequences to Request

When ordering MRI, the following sequences should be included 1, 4:

  • 3D T1 volumetric sequence with coronal reformations for hippocampal volume assessment
  • FLAIR (Fluid-Attenuated Inversion Recovery) for white matter lesions
  • T2-weighted imaging or susceptibility-weighted imaging (SWI) if available
  • Diffusion-weighted imaging (DWI) to detect acute pathology

CT as Alternative

CT head without contrast is acceptable when MRI cannot be performed (contraindications, unavailability, or patient intolerance), though it is less sensitive 1, 2. If CT is used, coronal reformations should be requested to better assess hippocampal atrophy 1.

When Imaging is Particularly Important

Neuroimaging should be prioritized when 3, 4:

  • Cognitive symptoms began within the past 2 years
  • Recent significant head trauma occurred
  • Unexplained neurological signs are present (new severe headache, seizures, gait disturbances)
  • History of cancer exists, particularly with risk for brain metastases
  • Risk factors for intracranial bleeding are present
  • Symptoms suggest normal pressure hydrocephalus
  • Significant vascular risk factors exist

Advanced Imaging Considerations

FDG-PET/CT or amyloid PET/CT should be reserved for cases where the diagnosis remains unclear after initial structural imaging and specialist evaluation 1. These studies:

  • Should be ordered by dementia specialists or cognitive disorders experts 1
  • Are complementary modalities with greater accuracy when used together 1
  • Help differentiate between dementia subtypes when structural imaging is inconclusive 1

SPECT perfusion imaging is an alternative if FDG-PET is unavailable 1, though PET is preferred when accessible.

Important Clinical Caveats

  • Advanced MRI sequences (MR spectroscopy, functional MRI, diffusion tensor imaging) are not recommended for routine clinical use 1, 3
  • IV contrast is not necessary for initial memory loss evaluation in most cases 1, 2
  • Semi-quantitative scales should be used when interpreting images, including the medial temporal lobe atrophy (MTA) scale, Fazekas scale for white matter changes, and global cortical atrophy (GCA) scale 1, 3
  • Most patients over age 80 have mixed pathology, making imaging findings supportive but not definitive for specific diagnoses 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

MRI Protocol for Dementia Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

MRI in Dementia Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Cognitive Decline Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.